In the context of AML pathogenesis, the high expression of GCNT2 in hematopoietic stem and progenitor cells implies a potential role in the self-renewal and proliferative capacity of leukemic stem cells (LSCs). The gene discussed is GCNT2; the disease is acute myeloid leukemia.